GIMIC Co., Ltd. (475A) Stock Price

Gimmick operates a platform business specializing in medical information, with its flagship product being "Doctors' File," a medical information website that aggregates content based on interviews with physicians. The company aims to provide patients with an information foundation to independently compare and select doctors and medical institutions, thereby reducing anxiety and distrust in their decision-making.

Primary customers include medical institutions such as clinics, hospitals, and veterinary hospitals, as well as patients and their families who use these facilities. Revenue is composed of approximately 70% from monthly subscription fees for "Doctors' File," approximately 20% from listing fees for "Reliable Doctor," and the remainder from other income sources including personnel placement and system provision. This subscription-centered model ensures stable recurring revenue.

The company's business is divided into four segments: matching services (Doctors' File, Hospitals' File, Reliable Doctor), human resources and personnel services (personnel placement agency, Clinico, HR Clinic), in-hospital operations (Medipathy, Apo Regitus), and medical collaboration services (D-Search, Medical Collaboration Guidebook, Medical Collaboration Events). Each service operates under diverse revenue models including monthly and annual fees, referral commissions, and listing fees, with the company pursuing growth through cross-selling to existing customers.

The company aims to enhance enterprise value by expanding its customer base and increasing stable recurring revenue, centered on its medical information platform "Doctors' File." As of September 2025, the company has 7,502 customers with approximately 4.4% market share in the clinic market, and annual recurring revenue (ARR) of approximately 2.7 billion yen. The company plans to grow sales and operating profit by further expanding these metrics. The company prioritizes maintaining a churn rate of around 0.74%, aiming to stabilize revenue through improved customer retention.

The company differentiates itself through strategic investments in product development, marketing, branding, and talent acquisition. Specifically, it leverages neutral and credible articles based on direct interviews with physicians as a key competitive advantage. Revenue composition consists of approximately 70% from "Doctors' File" monthly subscriptions, approximately 20% from "Trustworthy Doctor" listing fees, and the remainder from physician recruitment and system services. The company is executing initiatives to increase transaction value per customer through cross-selling to existing customers ("Trustworthy Doctor" has a 74.7% retention rate).

As a market expansion strategy, the company is pursuing a dominant strategy by concentrating on priority regions with established sales channels to accelerate customer acquisition. With approximately 170,000 clinics nationwide as the total addressable market and priority regions comprising approximately 114,000 clinics (66.2% of the total), the company aims to increase market share by first penetrating these areas. Additionally, the company is combining matching services with adjacent businesses such as in-clinic operational support, medical networking events, and system provision to increase customer touchpoints and drive business expansion through cross-selling and recurring revenue.

The company is actively pursuing technological innovation to improve productivity while maintaining quality. For example, by implementing artificial intelligence (AI) in the physician interview article production process, the company reduced the average production time from 7 days to 2 days, saving 5 days of production time. Going forward, the company will pursue both efficiency and reliability improvements through product feature expansion, system enhancement, information management strengthening, and recruitment of product development talent.